Golembiewski Michael Joseph 4
4 · SEELOS THERAPEUTICS, INC. · Filed Mar 2, 2023
Insider Transaction Report
Form 4
Golembiewski Michael Joseph
Chief Financial Officer
Transactions
- Award
Common Stock
2023-02-28$0.67/sh+12,500$8,400→ 90,987 total
Footnotes (1)
- [F1]These shares were acquired under the Company's 2020 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).